Please use this identifier to cite or link to this item:
http://doi.org/10.25358/openscience-8574
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Singh, Shreya | - |
dc.contributor.author | Patil, Anant | - |
dc.contributor.author | Kianfar, Nika | - |
dc.contributor.author | Waśkiel-Burnat, Anna | - |
dc.contributor.author | Rudnicka, Lidia | - |
dc.contributor.author | Sinclair, Rodney | - |
dc.contributor.author | Goldust, Mohamad | - |
dc.date.accessioned | 2023-01-16T11:42:02Z | - |
dc.date.available | 2023-01-16T11:42:02Z | - |
dc.date.issued | 2022 | - |
dc.identifier.uri | https://openscience.ub.uni-mainz.de/handle/20.500.12030/8590 | - |
dc.description.abstract | Minoxidil solution is used for the treatment of androgenetic alopecia (AGA). Minoxi dil 5% solution has been shown to have superior efficacy to minoxidil 2% solution, it is unknown whether concentrations of minoxidil > 5% provide additional clinical benefit. We performed a review of the literature to examine the evidence on the effi cacy and safety of higher concentrations of minoxidil in AGA. A search of the PubMed database was performed using the keywords ‘minoxidil’, ‘androgenic alope cia’ and ‘pattern hair loss’. Relevant articles, including clinical trials, other clinical studies, case series and case reports published in English were considered for review. In addition, relevant references from the bibliography section of the retrieved articles were also reviewed. | en_GB |
dc.description.sponsorship | Gefördert durch die Deutsche Forschungsgemeinschaft (DFG) - Projektnummer 491381577 | de |
dc.language.iso | eng | de |
dc.rights | CC BY | * |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | * |
dc.subject.ddc | 610 Medizin | de_DE |
dc.subject.ddc | 610 Medical sciences | en_GB |
dc.title | Does topical minoxidil at concentrations higher than 5% provide additional clinical benefit? | en_GB |
dc.type | Zeitschriftenaufsatz | de |
dc.identifier.doi | http://doi.org/10.25358/openscience-8574 | - |
jgu.type.dinitype | article | en_GB |
jgu.type.version | Published version | de |
jgu.type.resource | Text | de |
jgu.organisation.department | FB 04 Medizin | de |
jgu.organisation.number | 2700 | - |
jgu.organisation.name | Johannes Gutenberg-Universität Mainz | - |
jgu.rights.accessrights | openAccess | - |
jgu.journal.title | Clinical and experimental dermatology | de |
jgu.journal.volume | 47 | de |
jgu.journal.issue | 11 | de |
jgu.pages.start | 1951 | de |
jgu.pages.end | 1955 | de |
jgu.publisher.year | 2022 | - |
jgu.publisher.name | Wiley-Blackwell | de |
jgu.publisher.place | Oxford u.a. | de |
jgu.publisher.issn | 1365-2230 | de |
jgu.organisation.place | Mainz | - |
jgu.subject.ddccode | 610 | de |
jgu.publisher.doi | 10.1111/ced.15338 | de |
jgu.organisation.ror | https://ror.org/023b0x485 | - |
jgu.subject.dfg | Lebenswissenschaften | de |
Appears in collections: | DFG-491381577-H |
Files in This Item:
File | Description | Size | Format | ||
---|---|---|---|---|---|
does_topical_minoxidil_at_con-20230116123911545.pdf | 155.66 kB | Adobe PDF | View/Open |